Evidence map›Paper›PMID 36986186›Full record

Trial reportNutrients2023

Effects of Astaxanthin, Lutein, and Zeaxanthin on Eye-Hand Coordination and Smooth-Pursuit Eye Movement after Visual Display Terminal Operation in Healthy Subjects: A Randomized, Double-Blind Placebo-Controlled Intergroup Trial.

Keisuke Yoshida, Osamu Sakai, Tomoo Honda, Tomio Kikuya, Ryuji Takeda, Akiyoshi Sawabe, Masamaru Inaba, Chieko Koike

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. From "traditional" to modern medicine: A medical and historical analysis ofJournal of traditional and complementary medicine · 2025
    Review
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Keisuke YoshidaSenju Pharmaceutical, Co., Ltd., Osaka 541-0048, Japan.ORCID 0000-0003-1553-7655
Osamu SakaiSenju Pharmaceutical, Co., Ltd., Osaka 541-0048, Japan.
Tomoo HondaSenju Pharmaceutical, Co., Ltd., Osaka 541-0048, Japan.
Tomio KikuyaSenju Pharmaceutical, Co., Ltd., Osaka 541-0048, Japan.
Ryuji TakedaDepartment of Nutritional Sciences for Well-Being, Faculty of Health Sciences for Welfare, Kansai University of Welfare Sciences, Osaka 582-0026, Japan.ORCID 0000-0003-2342-3965
Akiyoshi SawabeDepartment of Applied Biological Chemistry, Faculty of Agriculture, Kindai University, Nara 631-8505, Japan.ORCID 0000-0002-9450-4562
Masamaru InabaInaba Eye Clinic, Osaka 530-0001, Japan.
Chieko KoikeCollege of Pharmaceutical Sciences, Ritsumeikan University, Shiga 525-8577, Japan.ORCID 0000-0002-1927-017X
Senju Pharmaceutical (Japan) · JPFutaba clinic · JPKansai University of Welfare Sciences · JPKindai University · JPRitsumeikan University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: The impairment of eye-hand coordination and smooth-pursuit eye movement caused by visual display terminal (VDT) operation is thought to impair daily living activities, for which no effective methods are currently known. On the other hand, various food ingredients, including astaxanthin, lutein, and zeaxanthin, are known to help improve the eye health of VDT operators. This study aimed to test the hypothesis that the combination of astaxanthin, lutein, and zeaxanthin can prevent the impairment of eye-hand coordination and smooth-pursuit eye movement caused by VDT operation. (2) Methods: We conducted a randomized, placebo-controlled, parallel-group clinical trial. Healthy subjects who regularly worked with VDTs were randomly assigned to the active and placebo groups. All of the subjects took soft capsules containing 6 mg of astaxanthin, 10 mg of lutein, and 2 mg of zeaxanthin or placebo soft capsules once daily for eight weeks. We evaluated the eye-hand coordination, smooth-pursuit eye movements, and macular pigment optical density (MPOD) at 0, two, four, and eight weeks after soft-capsule intake. (3) Results: The active group showed significantly improved eye-hand coordination after VDT operation at eight weeks. However, there was no clear improvement in the effect of the supplementation on smooth-pursuit eye movements. The active group also showed a significant increase in MPOD levels. (4) Conclusions: Consumption of a supplement containing astaxanthin, lutein, and zeaxanthin mitigates the decline of eye-hand coordination after VDT operation.

Indexed as

Macular DegenerationMacular PigmentDietary SupplementsDouble-Blind MethodEye MovementsHealthy VolunteersHumansLuteinVisual AcuityXanthophyllsZeaxanthinsastaxanthineLuteinMacular PigmentXanthophyllsZeaxanthinsastaxanthineye–hand coordinationluteinmacular pigment optical density (MPOD)smooth-pursuit eye movementsvisual display terminals (VDT)zeaxanthin

Identifiers

PMID36986186
PMCPMC10054128
OpenAlexW4327977322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.